MyOme received an undisclosed amount of funding to expand its rare disease testing, allowing it to identify more genetic conditions through more advanced genome analysis.
MyOme received an undisclosed amount of funding to expand its rare disease testing, allowing it to identify more genetic conditions through more advanced genome analysis.